Search research articles
Contact Us
Filters
Showing results (601-610 of 962) with videos related to
Page
of 97
Sort By:
Journal of the American Heart Association
|
October 30, 2018
Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model
Lotte Kaasenbrood, Deepak L Bhatt, Jannick A N Dorresteijn, et al.
Journal of the American Heart Association
|
October 7, 2022
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
Gary E Raskob, Walter Ageno, Gregory Albers, et al.
European Journal of Preventive Cardiology
|
February 8, 2025
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome
Gregory G Schwartz, Michael Szarek, Esther Reijnders, et al.
Journal of the American College of Cardiology
|
March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial
Robert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.
American Heart Journal
|
December 5, 2009
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group
Sunil V Rao, John Eikelboom, Ph Gabriel Steg, et al.
Circulation. Cardiovascular Interventions
|
February 24, 2022
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION
Benjamin E Peterson, Robert A Harrington, Gregg W Stone, et al.
The New England Journal of Medicine
|
September 1, 2025
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
Gilles Lemesle, Romain Didier, Philippe Gabriel Steg, et al.
Thrombosis and Haemostasis
|
March 17, 2017
Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status
Mark R Thomas, Dominick J Angiolillo, Marc P Bonaca, et al.
Indian Heart Journal
|
October 25, 2016
Cardiovascular risk profile and management of atrial fibrillation in India: Real world data from RealiseAF survey
C Narasimhan, Jagmohan Singh Verma, A G Ravi Kishore, et al.
European Heart Journal
|
May 4, 2015
Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
Christoph Varenhorst, Niclas Eriksson, Åsa Johansson, et al.
Page
of 97
Search research articles
Search
Showing results (601-610 of 962) with videos related to
Sort By:
Page
of 97
Journal of the American Heart Association
|
October 30, 2018
Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model
Lotte Kaasenbrood, Deepak L Bhatt, Jannick A N Dorresteijn, et al.
Journal of the American Heart Association
|
October 7, 2022
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
Gary E Raskob, Walter Ageno, Gregory Albers, et al.
European Journal of Preventive Cardiology
|
February 8, 2025
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome
Gregory G Schwartz, Michael Szarek, Esther Reijnders, et al.
Journal of the American College of Cardiology
|
March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial
Robert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.
American Heart Journal
|
December 5, 2009
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group
Sunil V Rao, John Eikelboom, Ph Gabriel Steg, et al.
Circulation. Cardiovascular Interventions
|
February 24, 2022
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION
Benjamin E Peterson, Robert A Harrington, Gregg W Stone, et al.
The New England Journal of Medicine
|
September 1, 2025
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
Gilles Lemesle, Romain Didier, Philippe Gabriel Steg, et al.
Thrombosis and Haemostasis
|
March 17, 2017
Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status
Mark R Thomas, Dominick J Angiolillo, Marc P Bonaca, et al.
Indian Heart Journal
|
October 25, 2016
Cardiovascular risk profile and management of atrial fibrillation in India: Real world data from RealiseAF survey
C Narasimhan, Jagmohan Singh Verma, A G Ravi Kishore, et al.
European Heart Journal
|
May 4, 2015
Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
Christoph Varenhorst, Niclas Eriksson, Åsa Johansson, et al.
Page
of 97